The healthcare services provider revised its full-year guidance upward after strong Q2 2026 performance.
Pennant Group raised its 2026 revenue forecast to a range of $1.17 billion to $1.19 billion, up from prior guidance. The company also increased its earnings per share outlook to $1.34-$1.41, citing operational improvements and effective transitions in recent acquisitions.
The revised guidance follows a strong Q2 2026 performance, which management attributed to disciplined execution and cost controls. Earlier projections had set a lower revenue range, but the company now expects to exceed its initial targets.
Shares of PNTG showed limited immediate reaction to the announcement, as investors digested the updated financial outlook.